Registry of Malignant Arrhythmias and Sudden Cardiac Death - Influence of Diagnostics and Interventions
试验速览
- 阶段
- 不适用
- 入组人数
- 3,200
- 试验地点
- 1
- 主要终点
- Incidence of ventricular arrythmias (i.e. ventricular fibrillation, ventricular tachykardia, asystole, SCD)
研究概览
简要总结
The "Registry of Malignant Arrhythmias and Sudden Cardiac Death - Influence of Diagnostics and Interventions (RACE-IT)" represents a mono-centric registry of patients being hospitalized suffering from malignant arrythmias (ventricular tachycardia or fibrillation) and sudden cardiac death (SCD).
Detailed findings of patients' clinical outcome regarding mortality and co-morbidities related to the presence of invasive diagnostics or therapies including coronary angiography, percutaneous coronary intervention (PCI), electrophysiological testing (EP), catheter ablation and implanted cardiac devices (e.g. implantable cardioverter-defibrillators) will be documented. Patients will be included when being hospitalized from the year 2004 until today.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Hospitalization due to:
- •ventricular tachycardia
- •ventricular fibrillation
- •sudden cardiac death
排除标准
- •not diagnosed with one or more of the above
结局指标
主要结局
Incidence of ventricular arrythmias (i.e. ventricular fibrillation, ventricular tachykardia, asystole, SCD)
时间窗: Through study completion, potentially up to 12 years, depending on patient inclusion/first event and patients lifetime
次要结局
- Incidence of coronary artery disease (CAD) and PCI in patients with VF/VT/SCD(Through study completion, potentially up to 12 years, depending on patient inclusion/first event and patients lifetime)
- Incidences of recurrent malignant tachycardias, all-cause mortality, arrhythmia-related death, re-PCI/ACVB, re-ablation, further therapy with cardiac devices(Through study completion, potentially up to 12 years, depending on patient inclusion/first event and patients lifetime)
- Incidence of treatment with cardiac devices (i.e. ICD, CCM, CRT-D)(Through study completion, potentially up to 12 years, depending on patient inclusion/first event and patients lifetime)
- Incidence of invasive electrophysiologic testing (EP) and catheter ablation(Through study completion, potentially up to 12 years, depending on patient inclusion/first event and patients lifetime)
研究者
Michael Behnes
Sub-PI
Universitätsmedizin Mannheim